Copeptin and risk stratification in patients with ischemic stroke and transient ischemic attack: The CoRisk Study

International Journal of Stroke

Volumn 8, Issue 3, 2013, Pages 214-218

  De Marchis, Gian Marco ^a   Katan, Mira ^b   Weck, Anja ^a   Brekenfeld, Caspar ^c   Mattle, Heinrich P ^a   Buhl, Daniela ^c   Müller, Beat ^d   Christ Crain, Mirjam ^b   Arnold, Marcel ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

^d Kantonsspital Aarau ^*  (Switzerland)

Author keywords

Biomarker; Copeptin; Risk stratification; Stroke; Thrombolysis; TIA

Indexed keywords

COPEPTIN;

ARTICLE; ASPIRATION PNEUMONIA; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONSERVATIVE TREATMENT; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; RISK ASSESSMENT; SEIZURE; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; TREATMENT RESPONSE;

BIOLOGICAL MARKERS; DISABLED PERSONS; GLYCOPEPTIDES; HOSPITAL MORTALITY; HUMANS; ISCHEMIC ATTACK, TRANSIENT; PROSPECTIVE STUDIES; RECURRENCE; RISK ASSESSMENT; SAMPLE SIZE; STROKE; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 84871976758     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2011.00762.x     Document Type: Article

References (25)

1. Adams HP, Davis PH, Leira EC etal. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 1999; 53:126-131.
2. Lees KR, Bluhmki E, von Kummer R etal. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010; 375:1695-1703.
3. Counsell C, Dennis M, McDowall M. Predicting functional outcome in acute stroke: comparison of a simple six variable model with other predictive systems and informal clinical prediction. J Neurol Neurosurg Psychiatry 2004; 75:401-405.
4. 2 score predicts patients most likely to have true transient ischemic attack. Stroke 2008; 39:3096-3098.
5. Whiteley W, Chong WL, Sengupta A, Sandercock P. Blood markers for the prognosis of ischemic stroke: a systematic review. Stroke 2009; 40:e380-389.
6. Katan M, Fluri F, Morgenthaler NG etal. Copeptin: a novel, independent prognostic marker in patients with ischemic stroke. Ann Neurol 2009; 66:799-808.
7. Katan M, Nigro N, Fluri F etal. Stress hormones predict cerebrovascular re-events after transient ischemic attacks. Neurology 2011; 76:563-566.
8. Hosmer DW, Hosmer T, Le Cessie S, Lemeshow S. A comparison of goodness-of-fit tests for the logistic regression model. Stat Med 1997; 16:965-980.
9. Pencina MJ, D'Agostino RB, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27:157-172.
10. Hlatky MA, Greenland P, Arnett DK etal. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation 2009; 119:2408-2416.
11. Katan M, Elkind MS. Inflammatory and neuroendocrine biomarkers of prognosis after ischemic stroke. Expert Rev Neurother 2011; 11:225-239.
12. Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T. Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ 1980; 58:113-130.
13. Morgenthaler N, Struck J, Alonso C, Bergmann A. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 2006; 52:112-119.
14. Adams HP Jr, del Zoppo G, Alberts MJ etal. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 2007; 115:e478-534.
15. De Marchis GM, Kohler A, Renz N etal. Posterior versus anterior circulation strokes: comparison of clinical, radiological and outcome characteristics. J Neurol Neurosurg Psychiatry 2011; 82:33-37.
16. Goldstein L, Samsa G, Matchar D, Horner R. Charlson Index comorbidity adjustment for ischemic stroke outcome studies. Stroke 2004; 35:1941-1945.
17. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. JAMA 1998; 279:1265-1272.
18. Indredavik B, Rohweder G, Naalsund E, Lydersen S. Medical complications in a comprehensive stroke unit and an early supported discharge service. Stroke 2008; 39:414-420.
19. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. N Engl J Med 1985; 312:932-936.
20. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19:604-607.
21. Wahlgren N, Ahmed N, Davalos A etal. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007; 369:275-282.
22. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15:361-387.
23. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995; 333:1581-1587.
24. Goldstein LB, Simel DL. Is this patient having a stroke? JAMA 2005; 293:2391-2402.
25. Pencina MJ, D'Agostino RB, D'Agostino RB, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27:157-172.